Biofrontera (BFRI) stock Forecast for 2022 – 2026
Last update: 05-20-2022, 9:49Sector: Healthcare
The share price of Biofrontera Inc. (BFRI) now
What analysts predict:: $15.5
52-week high/low: $14.63 / $2.2
50/200 Day Moving Average: $3.361 / $4.217
This figure corresponds to the average price over the previous 50/200 days. For Biofrontera stocks, the 50-day moving average is the resistance level today.
For Biofrontera stocks, the 200-day moving average is the resistance level today.
Are you interested in Biofrontera Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Biofrontera stock price in 2022, 2023, 2024, 2025, 2026. How much will one Biofrontera share be worth in 2022 - 2026?
When should I take profit in Biofrontera stock? When should I record a loss on Biofrontera stock? What are analysts' forecasts for Biofrontera stock? What is the future of Biofrontera stock?
We forecast Biofrontera stock performance using neural networks based on historical data on Biofrontera stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Biofrontera stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Biofrontera shares. This happens once a day.
Historical and forecast chart of Biofrontera stock
The chart below shows the historical price of Biofrontera stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Biofrontera stock price can be found in the table below.
Long-term forecasts by years.
Biofrontera daily forecast for a month
Biofrontera Daily Price Targets
Biofrontera Stock Forecast 05-22-2022.
Pessimistic target level: 2.87
Optimistic target level: 2.98
Biofrontera Stock Forecast 05-23-2022.
Pessimistic target level: 2.87
Optimistic target level: 3.00
Biofrontera Stock Forecast 05-24-2022.
Pessimistic target level: 2.90
Optimistic target level: 3.04
Biofrontera Stock Forecast 05-25-2022.
Pessimistic target level: 2.88
Optimistic target level: 3.15
Biofrontera Stock Forecast 05-26-2022.
Pessimistic target level: 3.16
Optimistic target level: 3.31
Biofrontera Stock Forecast 05-27-2022.
Pessimistic target level: 3.16
Optimistic target level: 3.46
BFRI (BFRI) Monthly Stock Prediction for 2022
Biofrontera forecast for this year
Biofrontera Stock Prediction for Jun 2022
An downtrend is forecast for this month with an optimal target price of $2.59317. Pessimistic: $2.25. Optimistic: $2.92
Biofrontera Stock Prediction for Jul 2022
An downtrend is forecast for this month with an optimal target price of $2.4438. Pessimistic: $2.20. Optimistic: $2.73
Biofrontera Stock Prediction for Aug 2022
An downtrend is forecast for this month with an optimal target price of $2.32503. Pessimistic: $2.06. Optimistic: $2.46
Biofrontera Stock Prediction for Sep 2022
An downtrend is forecast for this month with an optimal target price of $2.03626. Pessimistic: $1.77. Optimistic: $2.20
Biofrontera Stock Prediction for Oct 2022
An downtrend is forecast for this month with an optimal target price of $1.73571. Pessimistic: $1.66. Optimistic: $1.84
Biofrontera Stock Prediction for Nov 2022
An uptrend is forecast for this month with an optimal target price of $1.79195. Pessimistic: $1.59. Optimistic: $2.03
Biofrontera Stock Prediction for Dec 2022
An downtrend is forecast for this month with an optimal target price of $1.79195. Pessimistic: $1.70. Optimistic: $2.02
Biofrontera (BFRI) Monthly Stock Prediction for 2023
Biofrontera (BFRI) Monthly Stock Prediction for 2024
Biofrontera (BFRI) Monthly Stock Prediction for 2025
Biofrontera (BFRI) Monthly Stock Prediction for 2026
Biofrontera information and performance
Biofrontera AG is a German biopharmaceutical company. The company develops medicines and medicinal cosmetics for the treatment of skin diseases and regenerative care for damaged skin. His portfolio includes: Ameluz, a photodynamic therapy (PDT) for actinic keratoses in development for other types of skin cancer and warts; BF-RhodoLED PDT lamp, used after treatment with Ameluz to eliminate infected cells; and Belixos, a dermatological cream with herbal ingredients for the care of itchy, inflamed and flaky skin and conditions such as insect bites, burns, neurodermatitis and psoriasis. The company is also in the clinical development of two candidate drugs: BF-derm1, a tablet with an inhibitor that blocks the synthesis of histamine in cells, which causes allergic reactions, and BF1, a selective serotonin receptor for the prevention of migraine. The company operates five wholly owned subsidiaries, notably Biofrontera Inc in the United States. Its main shareholder is MMF.
120 PRESIDENTIAL WAY,, SUITE 330, WOBURN, MA, US
Market Capitalization: 45 840 600 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: - $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: None
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: None
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: 0.07
Trailing PE: -
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: -
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: 3.248
Enterprise Value (EV) /Revenue
EV To EBITDA: -
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 17104700
Number of issued ordinary shares
Shares Float: N/A
Number of freely tradable shares
Shares Short Prior Month: N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.